Director, CMC Regulatory Affairs
Leads global CMC regulatory strategy for small molecule medicines, shaping development and approval pathways across international markets. Works at the intersection of R&D, supply, quality, and commercial functions to ensure regulatory compliance and uninterrupted patient access. Focuses on solving complex regulatory challenges, mentoring talent, and improving processes to support long-term product success.